Overlapping features between primary sclerosing cholangitis (PSC and autoimmune hepatitis (AIH) have previously been noted. To assess systematically similarities between these disorders, we have evaluated 114 PSC patients (36 women; 78 men), all confirmed by endoscopic retrograde cholangiography (ER
Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome
β Scribed by Ayman A. Abdo; Vincent G. Bain; Krikor Kichian; Samuel S. Lee
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 743 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
Recently, the autoimmune hepatitis (AIH)/primary sclerosing cholangitis (PSC) overlap syndrome has been reported increasingly. In this syndrome, patients present with features of both AIH and PSC. It has been suggested that the 2 diseases may be sequential in their occurrence, whereby patients have features of AIH and then after a number of years develop features of PSC, but clear confirmation of evolution has not been documented in adults. We describe 6 adult cases in which PSC was diagnosed many years after well-established AIH. Six patients are described in whom AIH definitely was diagnosed at presentation. No evidence of biliary disease was noted on the initial liver biopsy or endoscopic retrograde cholangiography (ERCP). All patients responded well to immunosuppressive therapy. After an average duration of follow-up of 4.6 years they became resistant to immunosuppression, and developed clear features of PSC, which was confirmed by ERCP in all patients. The average age of the patients at first presentation was 31.3 years, 2 were women and 4 were men, and 3 had ulcerative colitis. We found no specific features at presentation that could predict this evolutionary outcome. In conclusion, patients with well-established AIH can, after variable duration of follow-up, develop PSC. In patients with AIH who become resistant to immunosuppression or develop significant cholestasis, PSC should be ruled out by ERCP. (HEPATOLOGY 2002;36:1393-1399.) utoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) generally are considered to A be 2 separate autoimmune diseases of the liver.
More recently, the overlap syndrome, in which patients present with features of both AIH and PSC, has been well documented although no clear definition for this entity exists at this time.'-3 In all reported cases with overlap syndrome the patients had some features of both diseases at presentation. Some reports have suggested that the 2 diseases may be sequential in their occurrence, whereby patients have features of AIH and then after a number of years develop features of PSC.4,5 In all previous adult Abbreviations: AIH, autoimmune hepatitis; PSC, prima y sclerosing cholangitis;
π SIMILAR VOLUMES
1. Recurrence of primary sclerosing cholangitis. a Five percent of liver transplants are performed because of end-stage liver disease secondary to primary sclerosing cholangitis. b Recurrent disease affects 10% to 27% of recipients. c Diagnostic criteria of recurrence include the following: A confir
Children with primary sclerosing cholangitis or autoimmune chronic active hepatitis have similar high levels of immunoglobulin G and non-organ-specific autoantibodies and may have similar histological features. To investigate a possible immunopathogenesis of primary sclerosing cholangitis, we have s
The development of sclerosing cholangitis (SC) is observed in up to 50% of children followed up for autoimmune hepatitis (AIH). In adults, the prevalence is less known, although a recent study found evidence of SC in 10% of AIH patients using magnetic resonance cholangiopancreatography (MRCP). The a
Primary sclerosing cholangitis (PSC) is a chronic cho-may not be their main mechanism of antigen recognilestatic liver disease that is possibly an autoimmune distion. Evidence suggests that they may recognize antiease. Although gd T cells represent a small proportion gen presented by nonpolymorphic